This document outlines an exclusive GP-led secondary deal for Project Klein under SOF IV, expected to close in June 2018. The deal involves a mid-market buyout strategy focusing on Europe/UK, with investments in business services and healthcare services. Key investment data includes an invested capital of €60-100m, a discount to NAV of over 5%, and a gross multiple of 1.1x. The portfolio consists of four companies, including a UK premium distributor, a network of UK medical and cosmetics clinics, an Italian digital marketing company, and a management consulting company. Glendower Capital is leading the transaction, leveraging its track record in complex transactions and a long-standing relationship with the GP founder.
doj/DataSet10/EFTA01394011.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"June 2018","document_type":"tabular","key_locations":["Europe","UK","Italy"],"document_subtype":"investment summary","key_organizations":["Glendower Capital","Forrestal Capital LLC"]}